LeadIQ logo
Learn more at LeadIQ.com

Insights

Strategic partnerships Aspira has established high-profile collaborations with leading medical institutions such as Cleveland Clinic Abu Dhabi and University of Texas Medical Branch, signaling a strong open-door stance for joint biomarker discovery, validation, and expanded diagnostic offerings which can open co-development and revenue-sharing sales opportunities.

Noninvasive diagnostics The company focuses on non-invasive ovarian cancer risk assessment and endometriosis testing (OvaWatch, Ova1Plus, and ENDOinform development), presenting a compelling value proposition for healthcare providers seeking less invasive, accurate screening options to increase adoption and drive test volume.

AI powered growth Positioning as an AI-enhanced bio-analytical diagnostics player suggests opportunities to sell platform integrations, data analytics services, and advanced modeling capabilities to improve diagnostic accuracy and clinical utility for partner labs and hospitals.

Clinical adoption engine A large pipeline of FDA-cleared products alongside ongoing development indicates potential upsell opportunities to existing customers for additional tests (Ova1, Overa, OvaWatch) and future EndoCheck deployments as clinics seek comprehensive gynecologic health screening.

Funding and leadership momentum Recent financing activity, CFO appointment, board additions, and a growing partner network imply increasing organizational capability and credibility, creating favorable conditions for enterprise-level deals, large-scale lab service contracts, and longer-term procurement commitments.

Similar companies to Aspira Women's Health

Aspira Women's Health Tech Stack

Aspira Women's Health uses 8 technology products and services including iCIMS, Microsoft SharePoint, WordPress, and more. Explore Aspira Women's Health's tech stack below.

Media & News

Aspira Women's Health's Email Address Formats

Aspira Women's Health uses at least 6 email formats:
Aspira Women's Health Email FormatsExamplePercentage
FLast@aspirawh.comJDoe@aspirawh.com
87%
First.Last@aspirawh.comJohn.Doe@aspirawh.com
7%
Last@aspirawh.comDoe@aspirawh.com
4%
First@aspirawh.comJohn@aspirawh.com
2%
FLast@vermillion.comJDoe@vermillion.com
99%
First.Last@vermillion.comJohn.Doe@vermillion.com
1%

Frequently Asked Questions

What is Aspira Women's Health's phone number?

Minus sign iconPlus sign icon You can contact Aspira Women's Health's main corporate office by phone at
+1-510-226-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Aspira Women's Health's stock symbol?

Minus sign iconPlus sign iconAspira Women's Health is a publicly traded company; the company's stock symbol is AWH.

What is Aspira Women's Health's official website and social media links?

Minus sign iconPlus sign iconAspira Women's Health's official website is aspirawh.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Aspira Women's Health generate?

Minus sign iconPlus sign icon As of September 2026, Aspira Women's Health's annual revenue is estimated to be $25M - $50M.

What is Aspira Women's Health's SIC code and NAICS code?

Minus sign iconPlus sign iconAspira Women's Health's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Aspira Women's Health have currently?

Minus sign iconPlus sign iconAs of September 2026, Aspira Women's Health has approximately 59 employees across 2 continents, including North America and Europe. Key team members include Vice President Strategic Partnerships: K. G., Executive Chairwoman: V. P. and Regional Account Director: M. C. Explore Aspira Women's Health's employee directory with LeadIQ.

What industry does Aspira Women's Health belong to?

Minus sign iconPlus sign iconAspira Women's Health operates in the Biotechnology Research industry.

What technology does Aspira Women's Health use?

Minus sign iconPlus sign iconAspira Women's Health's tech stack includes iCIMS, Microsoft SharePoint, WordPress, Cookiebot, Salesforce, Shopify, Microsoft 365 and WP Engine.

What is Aspira Women's Health's email format?

Minus sign iconPlus sign iconAspira Women's Health's email format typically follows the pattern of FLast@aspirawh.com. Find more Aspira Women's Health email formats with LeadIQ.

How much funding has Aspira Women's Health raised to date?

Minus sign iconPlus sign icon As of September 2026, Aspira Women's Health has raised $153M in funding. The last funding round occurred on Oct 18, 2025 for $3.1M.

When was Aspira Women's Health founded?

Minus sign iconPlus sign iconAspira Women's Health was founded in 1993.
Aspira Women's Health logo

Aspira Women's Health

Biotechnology ResearchConnecticut, United States51-200 Employees

Aspira Women’s Health is a biotechnology research company focused on gynecologic health diagnostics, headquartered in Trumbull, Connecticut, and employing 51–200 people. It develops and markets ovarian cancer risk assessment tools under the OvaSuite portfolio, including OvaWatch, a non-invasive blood test used for initial risk assessment in women with benign or indeterminate adnexal masses. OvaWatch has a reported negative predictive value of 99%, enabling clinicians to rule out ovarian malignancy and guide patient management. The Ova1Plus offering combines FDA-cleared Ova1 and Overa tests to assess the risk of malignancy in women with adnexal masses planned for surgery. The company is pursuing a non-invasive diagnostic for endometriosis, EndoCheck, which is currently in development, and reports revenue in the range of $25–50 million.

Section iconCompany Overview

Phone number
+1-510-226-****
Website
aspirawh.com
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
AWH
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1993
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $153M

    Aspira Women's Health has raised a total of $153M of funding over 10 rounds. Their latest funding round was raised on Oct 18, 2025 in the amount of $3.1M as a Post IPO Equity.

  • $25M - $50M

    Aspira Women's Health's revenue is estimated to be in the range of $25M - $50M

Company Leadership

  • Vice President Strategic Partnerships at Aspira Women's Health
    K. G.
    Vice President Strategic Partnerships
    Mobile Phone
  • Executive Chairwoman at Aspira Women's Health
    V. P.
    Executive Chairwoman
    Mobile Phone
  • Regional Account Director at Aspira Women's Health
    M. C.
    Regional Account Director
    Mobile Phone
  • Director Of Regulatory Affairs And Quality Assurance at Aspira Women's Health
    E. C.
    Director Of Regulatory Affairs And Quality Assurance
    Mobile Phone
  • Director Of Sales Operations at Aspira Women's Health
    S. M.
    Director Of Sales Operations
    Mobile Phone

Employee Directory

  • Market Development Manager at Aspira Women's Health
    J. R. P.
    Market Development Manager
    Mobile Phone
  • Clinical Operations Manager at Aspira Women's Health
    K. N.
    Clinical Operations Manager
    Mobile Phone
  • Senior Regulatory Affairs And Quality Assurance Specialist at Aspira Women's Health
    T. F.
    Senior Regulatory Affairs And Quality Assurance Specialist
    Mobile Phone
  • Board Member at Aspira Women's Health
    E. B. D.
    Board Member
    Mobile Phone
  • Reimbursement Specialist at Aspira Women's Health
    C. C.
    Reimbursement Specialist
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.